John J McGrath1, Sukanta Saha1, Ali Al-Hamzawi1, Laura Andrade1, Corina Benjet1, Evelyn J Bromet1, Mark Oakley Browne1, Jose M Caldas de Almeida1, Wai Tat Chiu1, Koen Demyttenaere1, John Fayyad1, Silvia Florescu1, Giovanni de Girolamo1, Oye Gureje1, Josep Maria Haro1, Margreet Ten Have1, Chiyi Hu1, Viviane Kovess-Masfety1, Carmen C W Lim1, Fernando Navarro-Mateu1, Nancy Sampson1, José Posada-Villa1, Kenneth S Kendler1, Ronald C Kessler1. 1. From the Queensland Centre for Mental Health Research, Park Centre for Mental Health, Wacol, Australia; the Discipline of Psychiatry and the Queensland Brain Institute, University of Queensland, St. Lucia, Australia; the College of Medicine, Al-Qadisiya University, Diwania Governorate, Iraq; the Department and Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil; the Department of Epidemiologic and Psychosocial Research, National Institute of Psychiatry Ramon de la Fuente, Mexico City; the Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, N.Y.; the Centre for Mental Health, University of Melbourne, Melbourne, Australia; the Chronic Diseases Research Center (CEDOC) and the Department of Mental Health, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal; the Department of Health Care Policy, Harvard University, Boston; the Department of Psychiatry, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium; the Institute for Development, Research, Advocacy, and Applied Care (IDRAAC), Beirut, Lebanon; the National School of Public Health, Management, and Professional Development, Bucharest, Romania; IRCCS St. John of God Clinical Research Centre, IRCCS Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy; the Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Parc Sanitari Sant Joan de Deïu, CIBERSAM, Sant Boi de Llobregat, Barcelona, Spain; Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Utrecht; the Shenzhen Insitute of Mental Health and Shenzhen Kanging Hospital, Shenzhen, China; Ecole des Hautes Etudes en Santé Publique (EHESP), Paris Descartes University, Paris; the Department of Psychological Medicine, Dunedin School of Medicine, University of Otago, New Zealand; IMIB-Arrixaca, CIBERESP-Murcia, Subdirección General de Salud Mental y Asistencia Psiquiátrica, Servicio Murciano de Salud, El Palmar (Murcia), Spain; Colegio Mayor de Cundinamarca University, Bogotá, Colombia; and the Department of Psychiatry, Virginia Commonwealth University, Richmond.
Abstract
OBJECTIVE: While it is now recognized that psychotic experiences are associated with an increased risk of later mental disorders, we lack a detailed understanding of the reciprocal time-lagged relationships between first onsets of psychotic experiences and mental disorders. Using data from World Health Organization World Mental Health (WMH) Surveys, the authors assessed the bidirectional temporal associations between psychotic experiences and mental disorders. METHOD: The WMH Surveys assessed lifetime prevalence and age at onset of psychotic experiences and 21 common DSM-IV mental disorders among 31,261 adult respondents from 18 countries. Discrete-time survival models were used to examine bivariate and multivariate associations between psychotic experiences and mental disorders. RESULTS: Temporally primary psychotic experiences were significantly associated with subsequent first onset of eight of the 21 mental disorders (major depressive disorder, bipolar disorder, generalized anxiety disorder, social phobia, posttraumatic stress disorder, adult separation anxiety disorder, bulimia nervosa, and alcohol abuse), with odds ratios ranging from 1.3 (95% CI=1.2-1.5) for major depressive disorder to 2.0 (95% CI=1.5-2.6) for bipolar disorder. In contrast, 18 of 21 primary mental disorders were significantly associated with subsequent first onset of psychotic experiences, with odds ratios ranging from 1.5 (95% CI=1.0-2.1) for childhood separation anxiety disorder to 2.8 (95% CI=1.0-7.8) for anorexia nervosa. CONCLUSIONS: While temporally primary psychotic experiences are associated with an elevated risk of several subsequent mental disorders, these data show that most mental disorders are associated with an elevated risk of subsequent psychotic experiences. Further investigation of the underlying factors accounting for these time-order relationships may shed light on the etiology of psychotic experiences.
OBJECTIVE: While it is now recognized that psychotic experiences are associated with an increased risk of later mental disorders, we lack a detailed understanding of the reciprocal time-lagged relationships between first onsets of psychotic experiences and mental disorders. Using data from World Health Organization World Mental Health (WMH) Surveys, the authors assessed the bidirectional temporal associations between psychotic experiences and mental disorders. METHOD: The WMH Surveys assessed lifetime prevalence and age at onset of psychotic experiences and 21 common DSM-IV mental disorders among 31,261 adult respondents from 18 countries. Discrete-time survival models were used to examine bivariate and multivariate associations between psychotic experiences and mental disorders. RESULTS: Temporally primary psychotic experiences were significantly associated with subsequent first onset of eight of the 21 mental disorders (major depressive disorder, bipolar disorder, generalized anxiety disorder, social phobia, posttraumatic stress disorder, adult separation anxiety disorder, bulimia nervosa, and alcohol abuse), with odds ratios ranging from 1.3 (95% CI=1.2-1.5) for major depressive disorder to 2.0 (95% CI=1.5-2.6) for bipolar disorder. In contrast, 18 of 21 primary mental disorders were significantly associated with subsequent first onset of psychotic experiences, with odds ratios ranging from 1.5 (95% CI=1.0-2.1) for childhood separation anxiety disorder to 2.8 (95% CI=1.0-7.8) for anorexia nervosa. CONCLUSIONS: While temporally primary psychotic experiences are associated with an elevated risk of several subsequent mental disorders, these data show that most mental disorders are associated with an elevated risk of subsequent psychotic experiences. Further investigation of the underlying factors accounting for these time-order relationships may shed light on the etiology of psychotic experiences.
Authors: John McGrath; Joy Welham; James Scott; Daniel Varghese; Louisa Degenhardt; Mohammad Reza Hayatbakhsh; Rosa Alati; Gail M Williams; William Bor; Jake M Najman Journal: Arch Gen Psychiatry Date: 2010-03-01
Authors: Sukanta Saha; James G Scott; Amy K Johnston; Tim N Slade; Daniel Varghese; Gregory L Carter; John J McGrath Journal: Schizophr Res Date: 2011-08-03 Impact factor: 4.939
Authors: N Kaymaz; M Drukker; R Lieb; H-U Wittchen; N Werbeloff; M Weiser; T Lataster; J van Os Journal: Psychol Med Date: 2012-01-20 Impact factor: 7.723
Authors: Ronald C Kessler; Johan Ormel; Maria Petukhova; Katie A McLaughlin; Jennifer Greif Green; Leo J Russo; Dan J Stein; Alan M Zaslavsky; Sergio Aguilar-Gaxiola; Jordi Alonso; Laura Andrade; Corina Benjet; Giovanni de Girolamo; Ron de Graaf; Koen Demyttenaere; John Fayyad; Josep Maria Haro; Chi yi Hu; Aimee Karam; Sing Lee; Jean-Pierre Lepine; Herbert Matchsinger; Constanta Mihaescu-Pintia; Jose Posada-Villa; Rajesh Sagar; T Bedirhan Ustün Journal: Arch Gen Psychiatry Date: 2011-01
Authors: Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler Journal: Int J Methods Psychiatr Res Date: 2006 Impact factor: 4.035
Authors: Daniel Varghese; James Scott; Joy Welham; William Bor; Jake Najman; Michael O'Callaghan; Gail Williams; John McGrath Journal: Schizophr Bull Date: 2009-08-17 Impact factor: 9.306
Authors: Lotta-Katrin Pries; Sinan Guloksuz; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Nicole Gunther; Christian Rauschenberg; Ulrich Reininghaus; Rajiv Radhakrishnan; Maarten Bak; Bart P F Rutten; Jim van Os Journal: Schizophr Bull Date: 2018-06-06 Impact factor: 9.306
Authors: Y van der Steen; I Myin-Germeys; M van Nierop; M Ten Have; R de Graaf; S van Dorsselaer; J van Os; R van Winkel Journal: Epidemiol Psychiatr Sci Date: 2018-04-16 Impact factor: 6.892
Authors: Frank Iorfino; Elizabeth M Scott; Joanne S Carpenter; Shane P Cross; Daniel F Hermens; Madhura Killedar; Alissa Nichles; Natalia Zmicerevska; Django White; Adam J Guastella; Jan Scott; Patrick D McGorry; Ian B Hickie Journal: JAMA Psychiatry Date: 2019-11-01 Impact factor: 21.596
Authors: Maria Jalbrzikowski; David Freedman; Catherine E Hegarty; Eva Mennigen; Katherine H Karlsgodt; Loes M Olde Loohuis; Roel A Ophoff; Raquel E Gur; Carrie E Bearden Journal: J Am Acad Child Adolesc Psychiatry Date: 2019-01-18 Impact factor: 8.829
Authors: S Evans-Lacko; S Aguilar-Gaxiola; A Al-Hamzawi; J Alonso; C Benjet; R Bruffaerts; W T Chiu; S Florescu; G de Girolamo; O Gureje; J M Haro; Y He; C Hu; E G Karam; N Kawakami; S Lee; C Lund; V Kovess-Masfety; D Levinson; F Navarro-Mateu; B E Pennell; N A Sampson; K M Scott; H Tachimori; M Ten Have; M C Viana; D R Williams; B J Wojtyniak; Z Zarkov; R C Kessler; S Chatterji; G Thornicroft Journal: Psychol Med Date: 2017-11-27 Impact factor: 7.723
Authors: J J McGrath; K A McLaughlin; S Saha; S Aguilar-Gaxiola; A Al-Hamzawi; J Alonso; R Bruffaerts; G de Girolamo; P de Jonge; O Esan; S Florescu; O Gureje; J M Haro; C Hu; E G Karam; V Kovess-Masfety; S Lee; J P Lepine; C C W Lim; M E Medina-Mora; Z Mneimneh; B E Pennell; M Piazza; J Posada-Villa; N Sampson; M C Viana; M Xavier; E J Bromet; K S Kendler; R C Kessler Journal: Psychol Med Date: 2017-01-09 Impact factor: 7.723
Authors: Evelyn J Bromet; Matthew K Nock; Sukanta Saha; Carmen C W Lim; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Guilherme Borges; Ronny Bruffaerts; Louisa Degenhardt; Giovanni de Girolamo; Peter de Jonge; Silvia Florescu; Oye Gureje; Josep M Haro; Yanling He; Chiyi Hu; Elie G Karam; Viviane Kovess-Masfety; Sing Lee; Jean-Pierre Lepine; Zeina Mneimneh; Fernando Navarro-Mateu; Akin Ojagbemi; José Posada-Villa; Nancy A Sampson; Kate M Scott; Juan C Stagnaro; Maria C Viana; Miguel Xavier; Ronald C Kessler; John J McGrath Journal: JAMA Psychiatry Date: 2017-11-01 Impact factor: 21.596